4//SEC Filing
ALLOS THERAPEUTICS INC 4
Accession 0001290061-04-000027
CIK 0001097264operating
Filed
Sep 9, 8:00 PM ET
Accepted
Sep 10, 6:15 PM ET
Size
15.0 KB
Accession
0001290061-04-000027
Insider Transaction Report
Form 4
HERZIG MARKUS F
VP Regulatory Affairs
Transactions
- Award
Stock Options (Right to buy)
2004-09-08$2.28/sh+1,325$3,021→ 1,325 totalExercise: $2.28Exp: 2014-09-08→ Common Stock (1,325 underlying) - Award
Stock Options (Right to buy)
2004-09-08$2.28/sh+8,675$19,779→ 10,000 totalExercise: $2.28Exp: 2014-09-08→ Common Stock (8,675 underlying)
Holdings
- 17,584
Stock Options (Right to buy)
Exercise: $4.75From: 2003-04-03Exp: 2013-03-03→ Common Stock (17,584 underlying) - 6,905
Stock Options (Right to buy)
Exercise: $6.00From: 2003-03-01Exp: 2012-03-01→ Common Stock (6,905 underlying) - 3,587
Common Stock
- 65,000
Stock Options (Right to buy)
Exercise: $4.63From: 2002-07-30Exp: 2011-07-30→ Common Stock (65,000 underlying) - 30,000
Stock Options (Right to buy)
Exercise: $3.20From: 2003-06-03Exp: 2013-06-03→ Common Stock (30,000 underlying) - 12,560
Stock Options (Right to buy)
Exercise: $5.44From: 2005-03-01Exp: 2014-03-01→ Common Stock (12,560 underlying)
Footnotes (1)
- [F1]Stock options vest according to the following schedule: One fourth (1/4) of the total number of shares subject to this option shall vest 6 months after the vesting commencement date and an additional one twenty-fourths (1/24) of the total number of shares subject to the option become exercisable each one-month-period thereafter, until all such shares are exercisable.
Documents
Issuer
ALLOS THERAPEUTICS INC
CIK 0001097264
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001097264
Filing Metadata
- Form type
- 4
- Filed
- Sep 9, 8:00 PM ET
- Accepted
- Sep 10, 6:15 PM ET
- Size
- 15.0 KB